145 related articles for article (PubMed ID: 26036682)
1. The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.
Gao Y; Teng J; Hong Y; Qu F; Ren J; Li L; Pan X; Chen L; Yin L; Xu D; Cui X
Med Oncol; 2015 Jul; 32(7):518. PubMed ID: 26036682
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
Lin Z; Xiong L; Lin Q
Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.
Yu X; Zheng B; Chai R
Biosci Rep; 2014 Dec; 34(6):e00161. PubMed ID: 25370813
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.
Li H; Zhou F; Wang H; Lin D; Chen G; Zuo X; Sun L; Zhang X; Yang S
Biotechnol Appl Biochem; 2015; 62(5):615-20. PubMed ID: 25322666
[TBL] [Abstract][Full Text] [Related]
5. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
[TBL] [Abstract][Full Text] [Related]
6. RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.
Ren M; Zhou C; Liang H; Wang X; Xu L
Chem Biol Drug Des; 2015 Oct; 86(4):715-22. PubMed ID: 25682860
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.
Liu GZ; Liu JZ; Li XQ; Zhang L; Li SJ; Xiao TW; Wang JX; Li GY; Liu Y
Mol Cell Biochem; 2018 Jan; 438(1-2):191-198. PubMed ID: 28801778
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer.
Zeng T; Zhu L; Liao M; Zhuo W; Yang S; Wu W; Wang D
Med Oncol; 2017 Feb; 34(2):27. PubMed ID: 28078560
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
Fan Y; Guo Y
Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
[TBL] [Abstract][Full Text] [Related]
10. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
Wang D; Zhu L; Liao M; Zeng T; Zhuo W; Yang S; Wu W
Oncol Rep; 2016 Sep; 36(3):1285-92. PubMed ID: 27431378
[TBL] [Abstract][Full Text] [Related]
11. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of GPR137,G Protein-coupled receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells.
Ren J; Pan X; Li L; Huang Y; Huang H; Gao Y; Xu H; Qu F; Chen L; Wang L; Hong Y; Cui X; Xu D
Chem Biol Drug Des; 2016 May; 87(5):704-13. PubMed ID: 26669804
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
Yu S; Wang Y; Yuan H; Zhao H; Lv W; Chen J; Wan F; Liu D; Gao Z; Wu J
PLoS One; 2017; 12(1):e0171134. PubMed ID: 28125713
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ubiquitin associated protein 2-like inhibits the growth and migration of prostate cancer cells.
Li D; Huang Y
Oncol Rep; 2014 Oct; 32(4):1578-84. PubMed ID: 25069639
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
17. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
18. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.
Yi C; Wan X; Zhang Y; Fu F; Zhao C; Qin R; Wu H; Li Y; Huang Y
Int J Biochem Cell Biol; 2018 Sep; 102():138-150. PubMed ID: 30053504
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
[TBL] [Abstract][Full Text] [Related]
20. [Effect of p53-regulated apoptosis-inducing protein 1 transfection on the biological characteristics of PC-3M human prostate cancer cells].
Lin X; Zhao Q; Yin X; Tian R; Li F; Gao J; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):819-23. PubMed ID: 25108434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
